Olfactory dysfunction in patients with neuromyelitis optica
- PMID: 24187622
- PMCID: PMC3800619
- DOI: 10.1155/2013/654501
Olfactory dysfunction in patients with neuromyelitis optica
Abstract
Background. Neuromyelitis optica (NMO) is a severely disabling autoimmune disorder of the CNS, which mainly affects the optic nerves and spinal cord. However, recent studies have shown that extra-opticospinal are more common in NMO than previously thought. Objective. To investigate olfactory function (OF) in patients with neuromyelitis optica (NMO) versus healthy controls (HC). Methods. Psychophysical testing of the orthonasal OF was performed using the Threshold-Discrimination-Identification test (TDI), measuring different qualities of olfaction, in 10 unselected NMO patients and 10 HC. Results. Five of 10 NMO patients (50%) showed hyposmia, while all 10 HC were normosmic. Moreover, NMO patients had significantly lower mean TDI-scores compared to HC, based on a poorer performance in both the Discrimination and the Identification subtests. Conclusions. Our results suggest that hyposmia might be part of the expanding clinical spectrum of NMO.
Figures
References
-
- Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485–1489. - PubMed
-
- Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Ahlzheimer’s and Parkinson’s diseases. Archives of Neurology. 1998;55(1):84–90. - PubMed
-
- Doty RL, Li C, Mannon LJ, et al. Olfactory dysfunction in multiple sclerosis. The New England Journal of Medicine. 1997;337(7):p. 507. - PubMed
-
- Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. The Lancet Neurology. 2007;6(9):805–815. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
